IOBT Cash from 2010 to 2026
| IOBT Stock | USD 0.29 0.03 9.38% |
Cash | First Reported 2020-03-31 | Previous Quarter 28.1 M | Current Value 30.7 M | Quarterly Volatility 66.5 M |
Check IO Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IO Biotech's main balance sheet or income statement drivers, such as Net Interest Income of 5.7 M, Depreciation And Amortization of 725.9 K or Interest Expense of 3.3 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.41. IOBT financial statements analysis is a perfect complement when working with IO Biotech Valuation or Volatility modules.
IOBT | Cash | Build AI portfolio with IOBT Stock |
The evolution of Cash for IO Biotech provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how IO Biotech compares to historical norms and industry peers.
Latest IO Biotech's Cash Growth Pattern
Below is the plot of the Cash of IO Biotech over the last few years. Cash refers to the most liquid asset of IO Biotech, which is listed under current asset account on IO Biotech balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from IO Biotech customers. The amounts must be unrestricted with restricted cash listed in a different IO Biotech account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. IO Biotech's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IO Biotech's overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
IOBT Cash Regression Statistics
| Arithmetic Mean | 47,793,426 | |
| Geometric Mean | 19,027,474 | |
| Coefficient Of Variation | 135.01 | |
| Mean Deviation | 52,219,140 | |
| Median | 7,846,000 | |
| Standard Deviation | 64,523,863 | |
| Sample Variance | 4163.3T | |
| Range | 208.1M | |
| R-Value | 0.64 | |
| Mean Square Error | 2628.4T | |
| R-Squared | 0.41 | |
| Significance | 0.01 | |
| Slope | 8,162,976 | |
| Total Sum of Squares | 66613.3T |
IOBT Cash History
Other Fundumenentals of IO Biotech
IO Biotech Cash component correlations
Click cells to compare fundamentals
About IO Biotech Financial Statements
IO Biotech shareholders use historical fundamental indicators, such as Cash, to determine how well the company is positioned to perform in the future. Although IO Biotech investors may analyze each financial statement separately, they are all interrelated. The changes in IO Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses on on IO Biotech's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cash | 69 M | 104.2 M | |
| Cash And Short Term Investments | 69 M | 104.2 M | |
| Change In Cash | -74.8 M | -71.1 M | |
| Free Cash Flow | -74.2 M | -70.4 M | |
| Begin Period Cash Flow | 165 M | 94.8 M | |
| Total Cashflows From Investing Activities | -39.6 K | -41.6 K | |
| Other Cashflows From Financing Activities | -2.9 M | -2.7 M | |
| Other Non Cash Items | 3.2 M | 4.3 M | |
| Total Cash From Operating Activities | -74.1 M | -70.4 M | |
| End Period Cash Flow | 69.3 M | 104.4 M | |
| Cash And Cash Equivalents Changes | -54.4 M | -57.1 M | |
| Cash Flows Other Operating | 4.5 M | 4 M | |
| Free Cash Flow Yield | (1.22) | (1.28) | |
| Operating Cash Flow Per Share | (1.12) | (1.18) | |
| Free Cash Flow Per Share | (1.13) | (1.18) | |
| Cash Per Share | 1.05 | 1.00 | |
| EV To Operating Cash Flow | (0.03) | (0.03) | |
| EV To Free Cash Flow | (0.03) | (0.03) | |
| Price To Operating Cash Flows Ratio | (0.66) | (0.70) | |
| Price To Free Cash Flows Ratio | (0.66) | (0.70) | |
| Cash Ratio | 2.77 | 2.63 | |
| Cash Conversion Cycle | -1.8 K | -1.9 K | |
| Free Cash Flow Operating Cash Flow Ratio | 1.15 | 1.11 | |
| Cash Flow Coverage Ratios | (49.45) | (51.92) | |
| Price Cash Flow Ratio | (0.66) | (0.70) | |
| Cash Flow To Debt Ratio | (49.45) | (51.92) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for IOBT Stock Analysis
When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.